跳至主要内容
临床试验/JPRN-jRCT2080224618
JPRN-jRCT2080224618已完成1 期

A three-way crossover study to assess the relative bioavailability of 1-mg and 4-mg tablets of S-888711 and the effect of high-fat meals on the pharmacokinetics of the 4-mg tablet in healthy male subjects

SHIONOGI & CO., LTD.0 个研究点目标入组 15 人开始时间: 2019年3月28日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 39age old(—)
性别
Male

入选标准

  • Healthy adult male subjects between the ages >=20 and <40

排除标准

  • The subject who has a history of nervous, gastrointestinal, renal, hepatic, cardiovascular, psychiatric, respiratory, metabolic, endocrine, hematic and other clinically important disorder and were considered ineligible by the investigator or subinvestigator. Subjects whose family has a history of thrombosis, coagulation disorder, or thrombocytosis.

研究者

相似试验